Pituitary Stalk Interruption Syndrome – clinical Presentation and Management of a Potentially Life-threatening Disease in Newborns
PDF

Case Report

Pituitary Stalk Interruption Syndrome – clinical Presentation and Management of a Potentially Life-threatening Disease in Newborns

J Clin Res Pediatr Endocrinol 2025;17(1):109-114 DOI: 10.4274/jcrpe.galenos.2023.2023-1-23
, , , , , ,
PDF
Permissions

Abstract

Pituitary stalk interruption syndrome (PSIS) is a rare congenital disease resulting in hypopituitarism of variable degree. Serious courses, due to severe combined pituitary insufficiency, are even rarer and associated with very early manifestation immediately after birth. The first clinical signs are elusive and lead to delayed diagnosis and treatment, often resulting in life-threatening complications. The objective was to highlight early leading symptoms and key issues of PSIS in neonates to increase awareness, improve clinical management and thereby enable an early diagnosis and treatment to prevent further complications. This report presents and compares the clinical course and management of two male neonates with PSIS. Early leading symptoms were the same in both patients, including recurrent hypoglycaemia, hyponatraemia, jaundice, cholestasis, sucking weakness and genital abnormalities. Patient 1 developed an infection-induced adrenal crisis, persistent substitution-dependent thrombocytopenia and convulsions due to severe hypoglycaemia because of delayed PSIS diagnosis. In patient 2, with recognition of the leading symptoms, endocrine testing and a subsequent cerebral magnetic resonance imaging were performed early and he was diagnosed and treated before major complications occurred. Genetic testing was performed in both patients. A heterozygous variant in GLI2 [NM_005270.5:c.2537del; p.(Pro846Argfs*66)] was detected in patient 1. No potential PSIS-associated variant has been found in patient 2. In conclusion, the early diagnosis of neonatal PSIS is key to prompt treatment and prevention of potential severe clinical manifestation of this orphan disease. Therefore, increased awareness of early leading symptoms among clinicians caring for neonates will lead to improved care.

Keywords: Pituitary stalk interruption syndrome, hypopituitarism, neonatal manifestation, clinical management in newborns, neonatal cerebral magnetic resonance imaging, haematological abnormalities, GLI2 mutation

Read the full text

4 sections · 2 figures · 1 table · PDF

Create your free account to read the full text.

  • Full text with figures and tables
  • PDF and supplementary files
  • Access on every Galenos journal
Get free access

Already have an account?

Sign in
or
Continue with Google

One Galenos account works on every Galenos journal site.

References

1

Vergier J, Castinetti F, Saveanu A, Girard N, Brue T, Reynaud R. Diagnosis of endocrine disease: pituitary stalk interruption syndrome: etiology and clinical manifestations. Eur J Endocrinol. 2019;181:199-209.

2

Bar C, Zadro C, Diene G, Oliver I, Pienkowski C, Jouret B, Cartault A, Ajaltouni Z, Salles JP, Sevely A, Tauber M, Edouard T. Pituitary stalk interruption syndrome from infancy to adulthood: clinical, hormonal, and radiological assessment according to the initial presentation. PLoS One. 2015;10:e0142354.

3

Diwaker C, Thadani P, Memon SS, Sarathi V, Lila AR, Arya S, Krishnappa B, Karlekar M, Patil VA, Shah N, Bandgar T. Pituitary stalk interruption syndrome: phenotype, predictors, and pathophysiology of perinatal events. Pituitary. 2022;25:645-652. Epub 2022 Jun 24

4

Neubauer V, Griesmaier E, Baumgartner K, Mallouhi A, Keller M, Kiechl-Kohlendorfer U. Feasibility of cerebral MRI in non-sedated preterm-born infants at term-equivalent age: report of a single centre. Acta Paediatr. 2011;100:1544-1547. Epub 2011 Jul 8

5

Wang Q, Meng X, Sun Y, Liu F, Xu C, Qiao Y, Yang J, Li G, Wang Y. Hypoglycemia and jaundice in newborns with pituitary stalk interruption syndrome. Medicine (Baltimore). 2021;100:e25843.

6

Rathbun KM, Nguyen M, Singhal M. Addisonian Crisis. StatPearls. Treasure Island (FL). 2022.

7

Zwaveling-Soonawala N, Alders M, Jongejan A, Kovacic L, Duijkers FA, Maas SM, Fliers E, van Trotsenburg ASP, Hennekam RC. Clues for polygenic inheritance of pituitary stalk interruption syndrome from exome sequencing in 20 patients. J Clin Endocrinol Metab. 2018;103:415-428.

8

Lichiardopol C, Albulescu DM. Pituitary stalk interruption syndrome: report of two cases and literature review. Acta Endocrinol (Buchar). 2017;13:96-105.

9

Bear KA, Solomon BD, Antonini S, Arnhold IJ, França MM, Gerkes EH, Grange DK, Hadley DW, Jääskeläinen J, Paulo SS, Rump P, Stratakis CA, Thompson EM, Willis M, Winder TL, Jorge AA, Roessler E, Muenke M. Pathogenic mutations in GLI2 cause a specific phenotype that is distinct from holoprosencephaly. J Med Genet. 2014;51:413-418. Epub 2014 Apr 17

10

Arnhold IJ, França MM, Carvalho LR, Mendonca BB, Jorge AA. Role of GLI2 in hypopituitarism phenotype. J Mol Endocrinol. 2015;54:141-150. Epub 2015 Apr 15

11

Ghezali L, Liagre B, Limami Y, Beneytout JL, Leger DY. Sonic Hedgehog activation is implicated in diosgenin-induced megakaryocytic differentiation of human erythroleukemia cells. PLoS One. 2014;9:e95016.

12

Laway BA, Mir SA, Bashir MI, Bhat JR, Samoon J, Zargar AH. Prevalence of hematological abnormalities in patients with Sheehan’s syndrome: response to replacement of glucocorticoids and thyroxine. Pituitary. 2011;14:39-43.

13

Baez-Villasenor J, Rath CE, Finch CA. The blood picture in Addison’s disease. Blood. 1948;3:769-773.

14

Elmelhat AM, Khadora MM. A neonate with bicytopenia: unusual underlying etiology. Dubai Med J. 2019;2:54-58.

15

Klett M. Epidemiology of congenital hypothyroidism. Exp Clin Endocrinol Diabetes. 1997;105(Suppl 4):19-23.